...advanced device technologies for the treatment of obesity
Total raised: $71.3M
Investors 1
| Date | Name | Website |
| - | Longitude ... | longitudec... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 15.09.2016 | - | $7.5M | - |
| 24.11.2015 | Series D | $36.5M | - |
| 18.02.2013 | Series C | $27.3M | - |
Mentions in press and media 20
| Date | Title | Description |
| 23.04.2019 | BAROnova Announces FDA Approval of the TransPyloric Shuttle® (TPS®) Device | A First-in-Class, Non-Surgical Solution for Obesity Approved for One-Year of Device Treatment, Offering Patients Potentially More Durable Weight Loss and Health Benefits |
| 15.11.2018 | BAROnova’s TransPyloric Shuttle® (TPS®) Positive Pivotal Trial Data Presented at the 2018 Obesity Week Conference | Individuals Treated with TPS lost 3-fold More Weight Than Those in Sham-Controlled Placebo Arm |
| 17.07.2018 | BAROnova Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the TransPyloric Shuttle® (TPS®) Device Intended for the Treatment of Obesity | SAN CARLOS, Calif., /PRNewswire/ — BAROnova, Inc., announced today that it has submitted a Pre-Market Approval (PMA) application for the TransPyloric Shuttle device intended for the treatment of obesity to the Food and Drug Administration (... |
| 15.09.2016 | BAROnova Receives $7.5M Credit Facility | BAROnova, Inc., a San Carlos and Goleta, California-based clinical-stage medical device company, received a $7.5m credit facility. Square 1 Bank, a division of Pacific Western Bank, provided the financing. The company intends to use the pro... |
| 24.11.2015 | Daily funding roundup - November 24, 2015 | Placester secured $27M; Shiftgig raised $22M; Fortscale announced $16M funding Lenda, a first platform that allows homeowners to refinance their mortgage completely online, today announced the close of $2 million in seed funding led by Lake... |
| 24.11.2015 | BAROnova Secures $36.5M | GOLETA, CA, BAROnova, today announced it has closed a Series D financing of $36.5 million. >> Click here for more funding data on BAROnova >> To export BAROnova funding data to PDF and Excel, click here Delos Capital led ... |
| 23.11.2015 | BAROnova brings in $36.5M Series D for implanted weight-loss device | The TPS device, invented by BAROnova board member Daniel Burnett, MD, President and CEO of TheraNova, LLC., is easily inserted into the stomach through the mouth in a minimally invasive endoscopic procedure. The TPS is designed to cause the... |
| 23.11.2015 | BAROnova Closes $36.5 Million Series D Financing | GOLETA, Calif., Nov. 23, 2015 /PRNewswire/ — BAROnova, Inc., today announced it has closed a Series D financing of $36.5 million. Delos Capital led the round and Longitude Capital co-led the round, with participation from existing investors... |
| 07.01.2014 | Incubator with six venture-backed spinouts seeks 2014 exit, unveils new sepsis spinout | The six venture-backed spinouts include: Baronova, a startup trying for weight loss devices that are both non-surgical and non-pharma. The company closed a $27.3 million Series C round in February 2013, which was led by Boston Scientific (B... |
| 18.02.2013 | BAROnova Secures $27.3M Series C | GOLETA, CA, BAROnova announced the closing of its Series C financing of $27.3 million, led by investments from Sante Ventures and Boston Scientific Corporation. >> Click here for more funding data on BAROnova >> To export BA... |
Show more